每日对双日尼菲迪平GITS在严重的孕前:随机对照试验
Miranda K Kiefer1, Hayley Williams1, Oluchi Nwosu1
1Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, The Ohio State University, Columbus.
Hypertension (Dallas, Tex. : 1979)
|May 21, 2025
概括
尼菲迪平GITS 30毫克两次每天和每天60毫克显示出类似的血压控制与重症特征的先兆子. 然而,双日剂量减少了新兴抗高血压治疗的需要,这表明它可能是首选的治疗方案.
科学领域:
- 产科和妇科 产科和妇科
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 对于具有严重特征的孕前的最佳nifedipine胃肠道治疗系统 (GITS) 剂量仍然不清楚.
- 这项研究比较了尼菲迪平GITS30毫克每天两次 (BID) 与每天60毫克用于血压控制.
研究的目的:
- 为了评估nifedipine GITS 30 mg两次与每天60 mg相比在治疗严重产前的疗效.
- 确定尼菲迪平GITS的最佳剂量策略,适用于患有妊娠前症严重特征的孕妇.
主要方法:
- 一项随机对照试验,涉及怀孕个体 (怀孕22 0/7至33 5/7周) 患有先兆子和严重特征.
- 参与者被随机分配,在决定升级抗高血压治疗后,接受尼菲迪平GITS每天一次60毫克 (QD) 或每天两次30毫克.
- 测量的主要结果是随机化后24至48小时内低于最佳血压的百分比 (静脉压≥150mmHg或静脉压≥100mmHg).
主要成果:
- 在每天60毫克组 (34.2±29.4%) 和每天30毫克组 (32.8±34.0%;P=0.87) 之间没有观察到亚最佳血压百分比的显著差异.
- 新出现的抗高血压治疗的发生率在30毫克两次一天组 (14.8%) 与60毫克一天组 (46.2%;P=0.03) 相比,在30毫克两次一天组显着较低.
- 二次结果,包括分娩时的妊娠年龄和治疗方案的升级,在各组之间是相似的.
结论:
- 尼菲迪平GITS每天60毫克和每天两次30毫克显示,在严重的孕前中,低于最佳的血压控制率相当.
- 每天两次服用尼菲迪平GITS (30毫克两次) 可能是有利的,因为减少了对新出现的抗高血压干预的需求.
- 这一发现表明,在这种患者群体中,双日用剂量对管理严重血压升高的潜在益处.
相关概念视频
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
124
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
124
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
398
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
398
01:33Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K